Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-05-09 | Dr. Quart was Chief Executive Officer of Ardea Biosciences and has a Pharm.D. from University of California, San Francisco. |
| 2013-08-26 | Barry D. Quart, Pharm.D., Chief Executive Officer, Director |
| 2014-04-24 | Dr. Quart received his Pharm.D. from the University of California, San Francisco. Dr. Quart’s qualifications to serve on the Board include his senior management and director experience with other biotechnology and pharmaceutical companies and his prior drug development experience. |
| 2015-04-28 | Dr. Quart received a Pharm.D. degree from the University of California, San Francisco. Dr. Quart’s qualifications to serve on the Board include his experience in senior management and as a director with other biotechnology and pharmaceutical companies and his prior drug development experience. |
| 2016-04-29 | Dr. Quart received a Pharm.D. degree from the University of California, San Francisco. Dr. Quart’s qualifications to serve on our Board include his experience in senior management and as a director with other biotechnology and pharmaceutical companies and his prior drug development experience. |
| 2017-04-26 | Dr. Quart received a Pharm.D. degree from the University of California, San Francisco. Dr. Quart’s qualifications to serve on our Board include his experience in senior management and as a director with other biotechnology and pharmaceutical companies and his prior drug development experience. |
| 2018-04-30 | Dr. Quart received a Pharm.D. degree from the University of California, San Francisco. Dr. Quart’s qualifications to serve on our Board include his experience in senior management and as a director with other biotechnology and pharmaceutical companies and his prior drug development experience. |
Data sourced from SEC filings. Last updated: 2025-07-01